Track B report by Dr. Omar Sued
SUSA40: The Strategic Use of Antiretrovirals - Bringing HIV Prevention and Treatment Together
Sunday 22, 13:30 - 15:30
The WHO’s Director, Dr Margaret Chan reviewed the challenges of HIV
fight while recognized HIV as a shrinking epidemic. Her phrase “Strong
evidence support strong policies” and her passionate support of the B+
PMTCT option resulted in applaud from the public.
Dr. Harris described the process for updating the WHO ART guidelines
to include the best available evidence. In 2013, WHO will release the
new “Consolidated Guidelines on ARV for Treatment and Prevention of
HIV”; an expanded, clinical programmatic and operational guidance.
Dr Chirwa presented the Malawian experience in integrating HIV and
maternal care in 750 sites and the B+ PMTCT option. The intervention
increased the access and streamlined the services, doubling the annual
cases of people initiating ART in the country. Challenge remains, in
particular in human resources, infrastructure, adherence and funding.
Dr. Mean described the evolution of the HIV strategy in Cambodia that
resulted in 85% ART coverage in 2011. The declining of incident and
prevalent cases of HIV in the last years aimed the new goal of eliminate
HIV transmission in 2020 through linked responses, focus on key
population, case management and immediate treatment with <500 CD4.
A following panel, with countries representatives, partners,
implementers and advocates highlighted the WHO critical role in
providing guidance to the countries, called for the country
responsibility and leadership and the need of be flexible to
redistribute funds to higher impact interventions. Need to focus on
economic development, human rights and sound science was stressed.
Dr Chan closed praising for the right balance between idealism and
pragmatism. She recognized the inclusion of partners’ perspectives as an
added value of WHO, signaled the notorious absence of the Global Fund
in the discussion and supported the call for more transparency made by a
civil society participant.